Gene · 116
NIH grants1,702
NIH grants whose papers are about the gene, through NIH's grant-paper links.
681 to 700 of 1,702
Download this page as JSON| Grant | Title | ADCYAP1 papers | Newest fiscal year |
|---|---|---|---|
| R21AG059176 | IMPACT OF NOVEL REGULATORS OF TREM2 EXPRESSION ON ALZHEIMER'S DISEASE | 1 | 2019 |
| R21AI138165 | Ischemia / Reperfusion Injury Mediated TIM-3+CD4+ T Cell Exhaustion In Liver Transplant | 1 | 2019 |
| R21AT009034 | Neural basis for positive effects of breathing on emotional state | 1 | 2019 |
| R21CA229919 | Targeting Nodal/TGF-Beta pathway to inhibit invasion and growth of retinoblastoma | 1 | 2019 |
| R21EY028633 | Defining cell types of foveal and peripheral retina by high-throughput, single-celltranscriptional profiling | 1 | 2019 |
| R21MH113128 | Does REST make you resilient? | 1 | 2019 |
| R21NS104530 | Role of TRIM9 in regulating neurogenesis-associated hippocampal functions | 1 | 2019 |
| R21NS104990 | Peroxynitrite and Migraine | 1 | 2019 |
| R21NS109862 | Role of HDAC6 in cephalic pain | 1 | 2019 |
| R37NS028829 | Electrical Stimulation of Immediate Early Genes | 1 | 2019 |
| RF1AG052476 | Genome-wide Profiling of Brain DNA Hydroxymethylome in Alzheimer?sDisease | 1 | 2019 |
| RF1AG059082 | THERAPEUTIC STRATEGIES FOR ALZHEIMER'S DISEASE BASED ON TREM2 BIOLOGY | 1 | 2019 |
| RF1AG062661 | VGF peptide TLQP-21, a novel microglial C3aR1 modulator in Alzheimer's disease | 1 | 2019 |
| RF1MH117064 | Technology for functional study of cells and circuits in large postmortem brains ex vivo | 1 | 2019 |
| RF1NS110499 | Development of new photo-releasable neuropeptide nano-vesicles for studying modulation in the brain | 1 | 2019 |
| S10OD025132 | An AVANCE NEO 600 MHz NMR Spectrometer System for Structural and Chemical Biology | 1 | 2019 |
| T32GM008349 | Biotechnology Training Program | 1 | 2019 |
| T32GM113854 | Molecular Pharmacology Training Grant | 1 | 2019 |
| U01CA188388 | Modeling tumor-stroma crosstalk in lung cancer to identify targets for therapy | 1 | 2019 |
| U01CA194389 | Modeling the Molecular Determinants of Induced Anti-Tumor Immune Responses in Mantle Cell Lymphoma | 1 | 2019 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/116/grants?page=35